Filing Details
- Accession Number:
- 0001615219-20-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-20 16:07:57
- Reporting Period:
- 2020-02-19
- Accepted Time:
- 2020-02-20 16:07:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1615219 | Salarius Pharmaceuticals Inc. | SLRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1329154 | J Mark Rosenblum | C/O Salarius Pharmaceuticals, Inc. 2450 Holcombe Blvd., Suite J - 608 Houston TX 77021 | Exec Vp Finance, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-19 | 2,000 | $0.95 | 7,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
